Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
作者： Sagnik Bhattacharyya , Paul D Morrison , Paolo Fusar-Poli , Rocio Martin-Santos , Stefan Borgwardt
DOI: 10.1038/NPP.2009.184
关键词:
摘要: … Subjects were scanned on three occasions, each preceded by oral administration of Δ-9-THC, CBD, or placebo. BOLD responses were measured using fMRI. In a second experiment, …
nature.com
theroc.us参考文章(48)
A. W. Zuardi, R. A. Cosme, F. G. Graeff, F. S. Guimarães, Effects of ipsapirone and cannabidiol on human experimental anxiety. Journal of Psychopharmacology. ,vol. 7, pp. 82- 88 ,(1993) , 10.1177/026988119300700112
Deepak Cyril D’Souza, Walid Michel Abi-Saab, Steven Madonick, Kimberlee Forselius-Bielen, Anne Doersch, Gabriel Braley, Ralitza Gueorguieva, Thomas B. Cooper, John Harrison Krystal, Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry. ,vol. 57, pp. 594- 608 ,(2005) , 10.1016/J.BIOPSYCH.2004.12.006
Yosef Sarne, Raphael Mechoulam, Cannabinoids: Between Neuroprotection and Neurotoxicity Current Drug Targets - Cns & Neurological Disorders. ,vol. 4, pp. 677- 684 ,(2005) , 10.2174/156800705774933005
Paolo Fusar-Poli, José A. Crippa, Sagnik Bhattacharyya, Stefan J. Borgwardt, Paul Allen, Rocio Martin-Santos, Marc Seal, Simon A. Surguladze, Colin O’Carrol, Zerrin Atakan, Antonio W. Zuardi, Philip K. McGuire, Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing Archives of General Psychiatry. ,vol. 66, pp. 95- 105 ,(2009) , 10.1001/ARCHGENPSYCHIATRY.2008.519
A.Thomas McLellan, Harvey Kushner, David Metzger, Roger Peters, Iris Smith, Grant Grissom, Helen Pettinati, Milton Argeriou, The fifth edition of the addiction severity index Journal of Substance Abuse Treatment. ,vol. 9, pp. 199- 213 ,(1992) , 10.1016/0740-5472(92)90062-S
A. W. Zuardi, I. Shirakawa, E. Finkelfarb, I. G. Karniol, Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology. ,vol. 76, pp. 245- 250 ,(1982) , 10.1007/BF00432554
Sagnik Bhattacharyya, Paolo Fusar-Poli, Stefan Borgwardt, Rocio Martin-Santos, Chiara Nosarti, Colin O’Carroll, Paul Allen, Marc L. Seal, Paul C. Fletcher, José A. Crippa, Vincent Giampietro, Andrea Mechelli, Zerrin Atakan, Philip McGuire, Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol: A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis Archives of General Psychiatry. ,vol. 66, pp. 442- 451 ,(2009) , 10.1001/ARCHGENPSYCHIATRY.2009.17
Deepak Cyril D'Souza, Edward Perry, Lisa MacDougall, Yola Ammerman, Thomas Cooper, Yu-te Wu, Gabriel Braley, Ralitza Gueorguieva, John Harrison Krystal, The psychotomimetic effects of intravenous Delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis Neuropsychopharmacology. ,vol. 29, pp. 1558- 1572 ,(2004) , 10.1038/SJ.NPP.1300496
K Luan Phan, Mike Angstadt, Jamie Golden, Ikechukwu Onyewuenyi, Ana Popovska, Harriet De Wit, None, Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans The Journal of Neuroscience. ,vol. 28, pp. 2313- 2319 ,(2008) , 10.1523/JNEUROSCI.5603-07.2008
M. P. Viveros, R. Llorente, E. Moreno, E. M. Marco, Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behavioural Pharmacology. ,vol. 16, pp. 353- 362 ,(2005) , 10.1097/00008877-200509000-00007